Skip to main
THC

Tenet Healthcare (THC) Stock Forecast & Price Target

Tenet Healthcare (THC) Analyst Ratings

Based on 19 analyst ratings
Buy
Strong Buy 37%
Buy 58%
Hold 5%
Sell 0%
Strong Sell 0%

Bulls say

Tenet Healthcare is expected to face risks related to healthcare reform and policy changes, such as potential changes to Medicaid supplemental payment programs and Medicare coverage of bad debt. However, its ASC business is largely insulated from these potential headwinds. The recent expiration of enhanced ACA subsidies may also pose a challenge, but the company has shown growth in its surgical business and has maintained its overall financial guidance, indicating confidence in its performance. With solid 1Q results and potential upside in the future, TH

Bears say

Tenet Healthcare is facing several headwinds that will likely impact their bottom line, including decreasing hospital volumes, adverse payor mix shifts, and reduced reimbursement rates for exchange plans. Additionally, the company's high debt levels and aggressive acquisition strategy raise concerns about their ability to generate sustainable profits in the future. These factors, combined with the uncertainty surrounding healthcare policy in the US, make us believe that Tenet Healthcare's stock may underperform in the coming years.

Tenet Healthcare (THC) has been analyzed by 19 analysts, with a consensus rating of Buy. 37% of analysts recommend a Strong Buy, 58% recommend Buy, 5% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Tenet Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Tenet Healthcare (THC) Forecast

Analysts have given Tenet Healthcare (THC) a Buy based on their latest research and market trends.

According to 19 analysts, Tenet Healthcare (THC) has a Buy consensus rating as of May 15, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $239.47, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $239.47, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Tenet Healthcare (THC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.